Selected research
Market Structure
Global Continuous Glucose Monitor (CGM) Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Continuous Glucose Monitor (CGM) Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Continuous Glucose Monitor (CGM) Solution include Roche, Nutrisense, Levels Health, Eversense, Abbott, Dexcom, Medtronic, Changsha Sinocare and Beijing Yicheng Bioelectronics Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Continuous Glucose Monitor (CGM) Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Continuous Glucose Monitor (CGM) Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Continuous Glucose Monitor (CGM) Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Continuous Glucose Monitor (CGM) Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Continuous Glucose Monitor (CGM) Solution Segment by Company
Roche
Nutrisense
Levels Health
Eversense
Abbott
Dexcom
Medtronic
Changsha Sinocare
Beijing Yicheng Bioelectronics Technology
Ottai Technology (Wuxi)
Hangzhou MicroTech Medical
Continuous Glucose Monitor (CGM) Solution Segment by Type
Hardware
Software
Continuous Glucose Monitor (CGM) Solution Segment by Application
Clinical Treatment
Sports & Fitness
Others
Continuous Glucose Monitor (CGM) Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitor (CGM) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitor (CGM) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitor (CGM) Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Continuous Glucose Monitor (CGM) Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Continuous Glucose Monitor (CGM) Solution industry.
Chapter 3: Detailed analysis of Continuous Glucose Monitor (CGM) Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Continuous Glucose Monitor (CGM) Solutionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software
Applications
- Clinical Treatment
- Sports & Fitness
- Others
Companies covered
- Roche
- Nutrisense
- Levels Health
- Eversense
- Abbott
- Dexcom
- Medtronic
- Changsha Sinocare
- Beijing Yicheng Bioelectronics Technology
- Ottai Technology (Wuxi)
- Hangzhou MicroTech Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Hardware
- 1.2.3 Software
- 1.3 Market Analysis by Application
- 1.3.1 Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinical Treatment
- 1.3.3 Sports & Fitness
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Continuous Glucose Monitor (CGM) Solution Growth Trends by Region
- 1.5.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Continuous Glucose Monitor (CGM) Solution Market Size by Region (2021-2026)
- 1.5.3 Continuous Glucose Monitor (CGM) Solution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Continuous Glucose Monitor (CGM) Solution Market Dynamics
- 2.1 Continuous Glucose Monitor (CGM) Solution Industry Trends
- 2.2 Continuous Glucose Monitor (CGM) Solution Industry Drivers
- 2.3 Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges
- 2.4 Continuous Glucose Monitor (CGM) Solution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Continuous Glucose Monitor (CGM) Solution Revenue by Company (2021-2026)
- 3.2 Global Continuous Glucose Monitor (CGM) Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Continuous Glucose Monitor (CGM) Solution Key Company Head office and Area Served
- 3.4 Global Continuous Glucose Monitor (CGM) Solution Company, Product Type & Application
- 3.5 Global Continuous Glucose Monitor (CGM) Solution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Continuous Glucose Monitor (CGM) Solution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Continuous Glucose Monitor (CGM) Solution Players Market Share by Revenue in 2025
- 3.6.3 2025 Continuous Glucose Monitor (CGM) Solution Tier 1, Tier 2, and Tier 3
4 Continuous Glucose Monitor (CGM) Solution Market by Type
- 4.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2032)
- 4.3 Global Continuous Glucose Monitor (CGM) Solution Market Size Share by Type (2021-2032)
5 Continuous Glucose Monitor (CGM) Solution Market by Application
- 5.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2032)
- 5.3 Global Continuous Glucose Monitor (CGM) Solution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Company Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Nutrisense
- 6.2.1 Nutrisense Company Information
- 6.2.2 Nutrisense Business Overview
- 6.2.3 Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.2.5 Nutrisense Recent Developments
- 6.3 Levels Health
- 6.3.1 Levels Health Company Information
- 6.3.2 Levels Health Business Overview
- 6.3.3 Levels Health Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.3.5 Levels Health Recent Developments
- 6.4 Eversense
- 6.4.1 Eversense Company Information
- 6.4.2 Eversense Business Overview
- 6.4.3 Eversense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.4.5 Eversense Recent Developments
- 6.5 Abbott
- 6.5.1 Abbott Company Information
- 6.5.2 Abbott Business Overview
- 6.5.3 Abbott Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.5.5 Abbott Recent Developments
- 6.6 Dexcom
- 6.6.1 Dexcom Company Information
- 6.6.2 Dexcom Business Overview
- 6.6.3 Dexcom Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.6.5 Dexcom Recent Developments
- 6.7 Medtronic
- 6.7.1 Medtronic Company Information
- 6.7.2 Medtronic Business Overview
- 6.7.3 Medtronic Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.7.5 Medtronic Recent Developments
- 6.8 Changsha Sinocare
- 6.8.1 Changsha Sinocare Company Information
- 6.8.2 Changsha Sinocare Business Overview
- 6.8.3 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.8.5 Changsha Sinocare Recent Developments
- 6.9 Beijing Yicheng Bioelectronics Technology
- 6.9.1 Beijing Yicheng Bioelectronics Technology Company Information
- 6.9.2 Beijing Yicheng Bioelectronics Technology Business Overview
- 6.9.3 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.9.5 Beijing Yicheng Bioelectronics Technology Recent Developments
- 6.10 Ottai Technology (Wuxi)
- 6.10.1 Ottai Technology (Wuxi) Company Information
- 6.10.2 Ottai Technology (Wuxi) Business Overview
- 6.10.3 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.10.5 Ottai Technology (Wuxi) Recent Developments
- 6.11 Hangzhou MicroTech Medical
- 6.11.1 Hangzhou MicroTech Medical Company Information
- 6.11.2 Hangzhou MicroTech Medical Business Overview
- 6.11.3 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.11.5 Hangzhou MicroTech Medical Recent Developments
7 North America
- 7.1 North America Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 7.2 North America Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 7.2.1 North America Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2026)
- 7.2.2 North America Continuous Glucose Monitor (CGM) Solution Market Size by Type (2027-2032)
- 7.2.3 North America Continuous Glucose Monitor (CGM) Solution Market Share by Type (2021-2032)
- 7.3 North America Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 7.3.1 North America Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2026)
- 7.3.2 North America Continuous Glucose Monitor (CGM) Solution Market Size by Application (2027-2032)
- 7.3.3 North America Continuous Glucose Monitor (CGM) Solution Market Share by Application (2021-2032)
- 7.4 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country
- 7.4.1 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 7.4.3 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 7.4.4 North America Continuous Glucose Monitor (CGM) Solution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 8.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 8.2.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2026)
- 8.2.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Type (2027-2032)
- 8.2.3 Europe Continuous Glucose Monitor (CGM) Solution Market Share by Type (2021-2032)
- 8.3 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 8.3.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2026)
- 8.3.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Application (2027-2032)
- 8.3.3 Europe Continuous Glucose Monitor (CGM) Solution Market Share by Application (2021-2032)
- 8.4 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country
- 8.4.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 8.4.3 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 8.4.4 Europe Continuous Glucose Monitor (CGM) Solution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 9.2 China Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 9.2.1 China Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2026)
- 9.2.2 China Continuous Glucose Monitor (CGM) Solution Market Size by Type (2027-2032)
- 9.2.3 China Continuous Glucose Monitor (CGM) Solution Market Share by Type (2021-2032)
- 9.3 China Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 9.3.1 China Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2026)
- 9.3.2 China Continuous Glucose Monitor (CGM) Solution Market Size by Application (2027-2032)
- 9.3.3 China Continuous Glucose Monitor (CGM) Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 10.2 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 10.2.1 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2026)
- 10.2.2 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Type (2027-2032)
- 10.2.3 Asia Continuous Glucose Monitor (CGM) Solution Market Share by Type (2021-2032)
- 10.3 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 10.3.1 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2026)
- 10.3.2 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Application (2027-2032)
- 10.3.3 Asia Continuous Glucose Monitor (CGM) Solution Market Share by Application (2021-2032)
- 10.4 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Country
- 10.4.1 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 10.4.3 Asia Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 10.4.4 Asia Continuous Glucose Monitor (CGM) Solution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 11.2.1 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 11.3.1 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country
- 11.4.1 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst